Second-trimester sex hormone-binding globulin and subsequent development of pre-eclampsia

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 16, Issue 3, 2004, Pages 158-162

  Yu, C K H ^a   Papageorghiou, A T ^a   Bindra, R ^a   Spencer, K ^b   Nicolaides, K H ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b HAROLD WOOD HOSPITAL   (United Kingdom)

Author keywords

Pre eclampsia; Second trimester; SHBG

Indexed keywords

SEX HORMONE BINDING GLOBULIN;

ADULT; ARTICLE; BODY MASS; CHEMOLUMINESCENCE; CONTROLLED STUDY; DISEASE COURSE; DOPPLER FLOWMETRY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL PLASMA; PREECLAMPSIA; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; UNITED KINGDOM; UTERINE ARTERY;

ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; OSMOLAR CONCENTRATION; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, SECOND; SEX HORMONE-BINDING GLOBULIN;

EID: 10844280617     PISSN: 14767058     EISSN: None     Source Type: Journal    
DOI: 10.1080/14767050400013297     Document Type: Article

References (27)

1. Lyall F. The human placental bed revisited. Placenta 2002;23:555-62
2. Wilson ML, Goodwin TM, Pan VL, et al. Molecular epidemiology of pre-eclampsia. Obstet Gynecol Surv 2002; 39-66
3. Sagol S, Ozkinay E, Oztekin K, et al. The comparison of uterine artery Doppler velocimetry with the histopathology of the placental bed. Aust NZ J Obstet Gynaecol 1999;39:324-9
4. Papageorghiou AT, Yu CKH, Cicero S, et al. Second-trimester uterine artery Doppler screening in unselected populations: a review. J Matern Fetal Neonatal Med 2002;12: 78-88
5. Florio P, Reis FM, Pezzani I, et al. The addition of activin A and inhibin A measurement to uterine artery Doppler velocimetry to improve the early prediction of pre-eclampsia. Ultrasound Obstet Gynecol 2003;21:165-9
6. Sowers JR, Saleh AA, Sokol RJ. Hyperinsulinemia and insulin resistance are associated with preeclampsia in African-Americans. Am J Hypertens 1995;8:1-4
7. Solomon CG, Graves SW, Greene MF, et al. Glucose intolerance as a predictor of hypertension in pregnancy. Hypertension 1994;23:717-21
8. Kaaja R, Tikkanen MJ, Viinikka L, et al. Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet Gynecol 1995;85:353-6
9. Kaaja R. Insulin resistance syndrome in preeclampsia. Semin Reprod Endocrinol 1998;16:41-6
10. Lorentzen B, Endresen MJ, Hovig T, et al. Sera from preeclamptic women increase the content of triglycerides and reduce the release of prostacyclin in cultured endothelial cells. Thromb Res 1991;63:363-72
11. Anderson DC. Sex-hormone-binding globulin. Clin Endocrinol (Oxf) 1974;3:69-96
12. Plymate SR, Matej LA, Jones RE, et al. Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab 1988;67:460-4
13. Sherif K, Kushner H, Falkner BE. Sex hormone-binding globulin and insulin resistance in African-American women. Metabolism 1998;47:70-49
14. Lindstedt G, Lundberg PA, Lapidus L, et al. Low sex-hormone-binding globulin concentration as independent risk factor for development of NIDDM. 12-yr follow-up of population study of women in Gothenburg, Sweden. Diabetes 1991;40:123-8
15. Papageorghiou AT, Yu CKH, Bindra R, et al. Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstet Gynecol 2001;18:441-9
16. Brown MA, Lindheimer MD, de Swiet M, et al. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001;20:IX-XIV
17. Yudkin PL, Aboualfa M, Eyre JA, et al. New birthweight and head circumference centiles for gestational ages 24-42 weeks. Early Hum Dev 1987;15:45-52
18. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-9
19. Wolf M, Sandler L, Munoz K, et al. First trimester insulin resistance and subsequent preeclampsia: a prospective study. J Clin Endocrinol Metab 2002;87:1563-8
20. Kerlan V, Nahoul K, Le Martelot MT, et al. Longitudinal study of maternal plasma bioavailable testosterone and androstanediol glucuronide levels during pregnancy. Clin Endocrinol (Oxf) 1994;40:263-7
21. O'Leary P, Boyne P, Flett P, et al. Longitudinal assessment of changes in reproductive hormones during normal pregnancy. Clin Chem 1991;37:667-72
22. Catalano PM, Tyzbir ED, Roman NM et al. Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol 1991;165:1667-72
23. Stanley K, Fraser R, Bruce C. Physiological changes in insulin resistance in human pregnancy: longitudinal study with the hyperinsulinaemic euglycaemic clamp technique. Br J Obstet Gynaecol 1998;105:756-9
24. Hamilton-Fairley D, White D, Griffiths M, et al. Diurnal variation of sex hormone binding globulin and insulin-like growth factor binding protein-1 in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 1995;43:159-65
25. Key TJ, Pike MC, Moore JW, et al. The relationship of free fatty acids with the binding of oestradiol to SHBG and to albumin in women. J Steroid Biochem 1990;35:35-8
26. Laivuori H, Tikkanen MJ, Ylikorkala O. Hyperinsulinemia 17 years after preeclamptic first pregnancy. J Clin Endocrinol Metab 1996;81:2908-11
27. Nisell H, Erikssen C, Persson B, et al. Is carbohydrate metabolism altered among women who have undergone a preeclamptic pregnancy? Gynecol Obstet Invest 1999;48:241-6